PK of Tenofovir, Emtricitabine and Efavirenz in Healthy Volunteers
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to look at the levels of three HIV medications: tenofovir,
emtricitabine, and efavirenz in blood after the drug intake has been stopped in order to
understand how long these drugs persist in the blood. The study will specifically look at
blood levels of these three drugs (taken as a 3-in-1 tablet) after taking them every day for
14 days.
This study is not randomised which means that all subjects will receive all study medications
in the same order. You and the study doctor will know which study medications you are taking
at all times during the study.
Phase:
Phase 1
Details
Lead Sponsor:
St Stephens Aids Trust
Treatments:
Efavirenz Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination Emtricitabine Tenofovir